56Indexed trials
Market Rank #42 · Evidence Tier A
Serbia
Neuroscience Intelligence
Serbia neuroscience intelligence: 56 indexed trials, 5 institutions, research score 25.27.
12Recruiting
5Research institutions
25.3Research score
Evidence profile
35Sponsors
16Disease areas
0Institution works
0Institution citations
Model signals
Opportunity 25 · ML priority 25 · Confidence 85 · Evidence 25.3
These are comparative evidence signals. They do not represent a guarantee of market size or commercial outcome.
Leading disease areas
epilepsy8trials
alzheimers7trials
multiple_sclerosis5trials
neuromuscular5trials
parkinsons5trials
schizophrenia5trials
depression3trials
autism3trials
stroke2trials
bipolar_disorder2trials
Leading indexed sponsors
Sumitomo Pharma America, Inc.5trials
AbbVie4trials
Hoffmann-La Roche4trials
Novo Nordisk A/S4trials
Eisai Limited3trials
Boehringer Ingelheim2trials
Italfarmaco2trials
Forest Laboratories2trials
H. Lundbeck A/S2trials
Celgene2trials